SCHEMBL7764976

SCHEMBL7764976

C=C1CC(C(C)(C)SC(c2ccccc2)(c2ccccc2)c2ccccc2)OC1=O

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TNKS O95271 1/20 0.32
TNKS2 Q9H2K2 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.30
USP2 O75604 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8398802 0.70 TNKS (0.34) TNKSTNKS2SMN1; SMN2
SCHEMBL7765004 0.70 KIF11 (0.33)
SCHEMBL12308063 0.62 ESR1 (0.44)
SCHEMBL34009 0.61 KIF11 (0.48)
SCHEMBL18981157 0.61
SCHEMBL8396111 0.61 MAOB (0.53)
SCHEMBL30528494 0.61 TNKS2 (0.41) TNKSTNKS2
Hydrogen Sulfide SCHEMBL28197187 0.59 KIF11 (0.46)
SCHEMBL28485167 0.59 MAPT (0.45)
SCHEMBL5698850 0.59 KIF11 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0639566-B1 CYCLIC COMPOUND SANTEN PHARMACEUTICAL CO LTD (JP) 2001-06-20 EP disclosed
US-5461158-A Immunodeficiency and autoimmune diseases SANTEN PHARMACEUTICAL CO., LTD. (JP) 1995-10-24 US disclosed
EP-0639566-A1 CYCLIC COMPOUND SANTEN PHARMACEUTICAL CO., LTD. (JP) 1995-02-22 EP disclosed